You are here

Tecelra

Adaptimmune, after bringing cell therapy to market, questions viability and cuts 2 preclinical

Fierce Biotech

Thu, 03/20/25 - 09:57 pm

Adaptimmune Therapeutics

FDA signs off on Adaptimmune's Tecelra as the first engineered cell therapy for a solid tumor

Fierce Pharma

Fri, 08/2/24 - 11:32 am

synovial sarcoma